Abdelaziz Fahem: HLH in the GCC – A New Regional Consensus for Diagnosis and Management
Abdelaziz Fahem, Vice President of Medical Affairs and Clinical Research at Hemara Bio, shared a post on LinkedIn about a recent article by Mohamed A. Yasin, published in Frontiers in Immunology, adding:
“HLH in the GCC finally has a consensus.
Our paper, ‘Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach,’ has just been published in Frontiers in Immunology.
This is a significant publication for the HLH community in the Gulf.
HLH is a rare and life-threatening hyperinflammatory syndrome where delayed recognition or inappropriate management can have serious consequences. Until now, there has been a need for region-specific recommendations reflecting the clinical realities and expertise of the GCC.
This consensus brings together 15 experts from all six GCC countries, using a structured modified Delphi process to develop recommendations covering key aspects of HLH diagnosis and management.
Publishing this work in Frontiers in Immunology, a well-established international immunology journal with an Impact Factor of 7.0, gives these GCC recommendations a much broader scientific platform and visibility.
A special thank you to Dr Hind Salama and Pr Mohamed Yassin, who led this important initiative, and to all the experts who contributed their time, experience and scientific input.
I am particularly pleased to have contributed to a project that combines international scientific standards with regional clinical expertise, addressing an important unmet need in rare disease care.”
Title: Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis in the Gulf Cooperation Council: a modified Delphi approach
Authors: Mohamed A. Yasin, Muna Al Rasheed, Murtadha Al Khabori, Yasser Wali, Abdelaziz Fahem, Afaf Al Battah, Cigdem Pala Ozturk, Hani Yousif Osman, Maha Sabkar, Mahmoud Marashi, Mozah Al Marshoodi, Nisreen Khalifa, Shehab Mohamed, Salam Al Kindi, Tarek E. Abouzeid, Hind Salama
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH